breast cancer
HER2+ metastatic
gastric or gastroesophageal junction adenocarcinoma
Rituxan (rituximab) 17
Non-Hodgkin’s lymphoma
Chronic lymphocytic leukemia
Rheumatoid arthritis
Granulomatosis with polyangiitis
Pemphigus vulgaris
Lantus (insulin glargine):18
Diabetes
Avonex (interferon beta-1α):19
Multiple sclerosis (MS)
Lucentis (ranibizumab):20
Age-related macular degeneration
Macular edema following retinal vein occlusion
Diabetic macular edema
Diabetic retinopathy
Myopic choroidal neovascularization
Neulasta (pegfilgrastim):21
Neutropenia
